Pilot study of pegylated interferon-alpha 2b in patients with essential thrombocythemia

2003 ◽  
Vol 51 (1) ◽  
pp. 81-86 ◽  
Author(s):  
Yesid Alvarado ◽  
Jorge Cortes ◽  
Srdan Verstovsek ◽  
Deborah Thomas ◽  
Stephan Faderl ◽  
...  
Keyword(s):  
Pilot Study ◽  
Interferon Alpha ◽  
Essential Thrombocythemia ◽  
Pegylated Interferon ◽  
Pegylated Interferon Alpha ◽  
Interferon Alpha 2B

Pegylated interferon alpha 2b for chronic hepatitis C

2009 ◽  
Author(s):  
Tahany Awad ◽  
Kristian Thorlund ◽  
Goran Hauser ◽  
Mahasen Mabrouk ◽  
Davor Stimac ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Interferon Alpha ◽  
Pegylated Interferon ◽  
Pegylated Interferon Alpha ◽  
Interferon Alpha 2B

Administration of low-dose epoetin-alpha facilitates adherence to ribavirin in triple therapy with pegylated interferon-alpha-2b and telaprevir

2014 ◽  
Vol 44 (10) ◽  
pp. E84-E91 ◽  
Author(s):  
Hisashi Ishida ◽  
Sadatsugu Sakane ◽  
Takashi Toyama ◽  
Keisuke Fukutomi ◽  
Keiichi Kimura ◽  
...  
Keyword(s):  
Triple Therapy ◽  
Interferon Alpha ◽  
Low Dose ◽  
Pegylated Interferon ◽  
Pegylated Interferon Alpha ◽  
Interferon Alpha 2B ◽  
Epoetin Alpha

scholarly journals Outcome of Pregnancy in the Era of Pegylated Interferon Alpha 2a in Females with Essential Thrombocythemia: An Experience from Qatar

2020 ◽  
Vol 13 (1) ◽  
pp. 336-340
Author(s):  
Mohammad Abu-Tineh ◽  
Nancy Kassem ◽  
Mohammad Abdul-Jaber Abdulla ◽  
Omar Mohammad Ismail ◽  
Rola Ghasoub ◽  
...  
Keyword(s):  
Interferon Alpha ◽  
Essential Thrombocythemia ◽  
Myeloproliferative Neoplasms ◽  
Pegylated Interferon ◽  
Myelogenous Leukemia ◽  
Hematopoietic Stem ◽  
Pegylated Interferon Alpha ◽  
Pregnant Females ◽  
Increased Risk ◽  
Hemorrhagic Complications

Myeloproliferative neoplasms are a diversified group of diseases of the hematopoietic stem cell, such as essential thrombocythemia (ET) and polycythemia vera. They are mainly caused by mutations in the following genes: JAK2, CALR, and MPL. All carry an increased risk to transform into acute leukemia or chronic myelogenous leukemia along with thrombosis and hemorrhagic complications. Treatment of such disorders during pregnancy is a challenging footstep, given the high risk of complications for both the mother and the fetus. Here, we report about two pregnant females with ET that has been treated with pegylated interferon alpha with safe and effective outcome.

Histological improvement in patients with pegylated interferon alpha-2b plus ribavirin who were previously non-responders to rebetron

2003 ◽  
Vol 124 (4) ◽  
pp. A701
Author(s):  
Khaled Selin ◽  
Christopher Hyun ◽  
Jonathan Jensen ◽  
Stephen J. Rossi ◽  
Kip Lyche ◽  
...  
Keyword(s):  
Interferon Alpha ◽  
Pegylated Interferon ◽  
Pegylated Interferon Alpha ◽  
Interferon Alpha 2B ◽  
Histological Improvement
Sign in / Sign up

Export Citation Format

Share Document